CEVA INC
For the period ended Sep 30, 2024. Filed Nov 8, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 8, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to the Interim Condensed Consolidated Financial Statements
| NOTE 1: | BUSINESS |
|---|
The financial information in this quarterly report includes the results of Ceva, Inc. and its subsidiaries (the “Company” or “Ceva”).
Ceva is the leader in innovative silicon and software IP solutions that enable smart edge products to connect, sense, and infer data more reliably and efficiently. With the industry’s only portfolio of comprehensive communications and scalable edge AI IP, Ceva powers the connectivity, sensing, and inference in today’s most advanced smart edge products across consumer IoT, mobile, automotive, infrastructure, industrial, and personal computing. More than 18 billion of the world’s most innovative smart edge products from AI-infused smartwatches, IoT devices and wearables to autonomous vehicles, 5G mobile networks and more are powered by Ceva.
Ceva is a trusted partner to many of the leading semiconductor and original equipment manufacturer (OEM) companies targeting a wide variety of cellular and IoT end markets, including mobile, PC, consumer, automotive, smart-home, surveillance, robotics, industrial and medical. The customers incorporate Ceva’s IP into application-specific integrated circuits (ASICs) and application-specific standard products (ASSPs) that they manufacture, market and sell to OEMs and original design manufacturers. Ceva’s application software IP is licensed primarily to OEMs who embed it in their System on Chip (SoC) designs to enhance the user experience, and OEMs also license Ceva’s hardware IP products and solutions for their SoC designs to create power-efficient, intelligent, secure and connected devices.
Ceva’s wireless communications, sensing and edge AI technologies are at the heart of some of today’s most advanced smart edge products. From Bluetooth connectivity, Wi-Fi, ultra-wide band (UWB) and 5G-Advanced platform IP for ubiquitous, robust communications, to scalable edge AI neural processing unit (NPU) IPs, sensor fusion processors and embedded application software that make devices smarter.
Ceva licenses its portfolio of wireless communications and scalable edge AI IP to its customers, breaking down barriers to entry and enabling them to bring new cutting-edge products to market faster, more reliably, efficiently and economically.
| NOTE 2: | BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
|---|
Basis of Presentation
The interim condensed consolidated financial statements have been prepared according to U.S. Generally Accepted Accounting Principles (“U.S. GAAP”).
The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2024, are not necessarily indicative of the results that may be expected for the year ending December 31, 2024. For further information, reference is made to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.
The significant accounting policies applied in the annual consolidated financial statements of the Company as of December 31, 2023, contained in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 7, 2024, have been applied consistently in these unaudited interim condensed consolidated financial statements.
Concentration of credit risk:
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents, bank deposits, marketable securities, foreign exchange contracts and trade receivables. The Company invests its surplus cash in cash deposits and marketable securities in financial institutions and has established guidelines relating to diversification and maturities to maintain safety and liquidity of the investments.
The majority of the Company’s cash and cash equivalents are invested in high grade certificates of deposits with major U.S., European and Israeli banks. Generally, cash and cash equivalents and bank deposits may be redeemed on demand and therefore minimal credit risk exists with respect to them. Nonetheless, deposits with these banks exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits or similar limits in foreign jurisdictions, to the extent such deposits are even insured in such foreign jurisdictions. Generally, these cash equivalents may be redeemed upon demand, and therefore management believes that they bear a lower risk. The short-term bank deposits are held in financial institutions that management believes are institutions with high credit standing and, accordingly, minimal credit risk from geographic or credit concentration. Furthermore, the Company holds an investment portfolio consisting principally of corporate bonds. The Company has the ability to hold such investments until recovery of temporary declines in market value or maturity.
The Company’s trade receivables are geographically diverse, mainly in the Asia Pacific region, and also in the United States and Europe. Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation and account monitoring procedures. The Company performs ongoing credit evaluations of its customers. The Company makes estimates of expected credit losses based upon its assessment of various factors, including historical experience, the age of the trade receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers.
During the nine-month period ended September 30, 2024, the Company recorded an additional allowance for credit losses in the amount to $800.
The Company has no off-balance-sheet concentration of credit risk.
Accounting Standards Recently Adopted by the Company
In June 2022, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update ("ASU") No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions, which clarifies the guidance when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security and introduces new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. The guidance is effective for annual periods beginning after December 15, 2023, with early adoption permitted. The Company adopted ASU 2022-03 as of January 1, 2024. The adoption did not result in a material impact on the Company's interim condensed financial statements.
Accounting Standards Recently Issued, Not Yet Adopted by the Company
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose information about their reportable segments’ significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280 on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-07.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires public entities, on an annual basis, to provide disclosure of specific categories in the rate reconciliation, as well as disclosure of income taxes paid disaggregated by jurisdiction. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-09.
Use of Estimates
The preparation of the interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates of the financial statements, the reported amounts of revenues and expenses during the reporting period, and amounts classified as a discontinued operation. Actual results could differ from those estimates.
| NOTE 3: | ACQUISITION |
|---|
In January 2024, the Company acquired 100% of the equity shares of a privately held, Greek-based company, to extend the research and development resources in the Ceva group. Under the terms of the purchase agreement, the Company agreed to pay an aggregate of approximately $750 paid at closing and approximately $2,100 subject to continued employment and certain performance milestones. The Company has accounted for this acquisition as an asset acquisition. As such, the total purchase consideration was allocated to the assets acquired.
| NOTE 4: | HELD FOR SALE AND DISCONTINUED OPERATION |
|---|
On September 14, 2023, the Company and Intrinsix, then its wholly owned subsidiary, entered into a Share Purchase Agreement (the “Agreement”) with Cadence Design Systems, Inc. (“Cadence”), pursuant to which Cadence agreed to purchase all of the issued and outstanding capital shares of Intrinsix from the Company for $35,000 in cash, subject to other certain purchase price adjustments as provided for in the Agreement (the “Transaction”). The closing of the Transaction occurred on October 2, 2023. At the closing, an amount of $300 from the consideration was deposited with a third-party escrow agent for the purposes of satisfying any additional post-closing purchase price adjustments owed by the Company to Cadence, which was fully paid to the Company during the first quarter of 2024, a further amount of $3,500 of the consideration was deposited with the same escrow agent for a period of 18 months as security for the Company’s indemnification obligations to Cadence in accordance with the terms and conditions set forth in the Agreement, and after giving effect to post-closing adjustments resulting in a $240 repayment to the Company during the first quarter of 2024. The Agreement includes certain representations, warranties and covenants of the parties, and the Company also agreed to certain non-competition and non-solicitation terms, which are subject to certain exceptions.
Under ASC 205-20, "Discontinued Operation" when a component of an entity, as defined in ASC 205-20, has been disposed of or is classified as held for sale, the results of its operations, including the gain or loss on its component, are classified as discontinued operations and the assets and liabilities of such component are classified as assets and liabilities attributed to discontinued operations; that is, provided that the operations, assets and liabilities and cash flows of the component have been eliminated from the Company’s consolidated operations and the Company will have no significant continuing involvement in the operations of the component.
As a result of the Transaction, Intrinsix's results of operations and asset and liability balances are disclosed as a discontinued operation. All prior periods comparable results of operation, assets and liabilities have been retroactively included in discontinued operations.
The following table shows the Company's results of discontinued operation for the below presented period:
| Nine months ended September 30, 2023 (unaudited) | Three months ended September 30, 2023 (unaudited) | |
|---|---|---|
| Revenues | $7,868 | $2,145 |
| Cost of revenue | 5,091 | 1,236 |
| Gross profit | 2,777 | 909 |
| Operating expenses: | ||
| Research and development, net | 5,464 | 1,809 |
| Sales and marketing | 679 | 190 |
| General and administrative | 1,472 | 993 |
| Amortization of intangible assets | 373 | 24 |
| Total operating expenses | 7,988 | 3,016 |
| Operating loss | (5,211) | (2,107) |
| Financial income, net | 3 | — |
| Loss from discontinued operations before taxes on income | (5,208) | (2,107) |
| Income tax expense | 100 | 100 |
| Net loss from discontinued operation | $(5,308) | $(2,207) |
The following table presents cash flows from discontinued operations:
| Nine months ended September 30, 2023 (unaudited) | |
|---|---|
| Net cash flow used in operating activities (*) | $(556) |
| Net cash flows used in investing activities | (5) |
(*)Amortization and depreciation allocated to discontinued operation for the nine-month period ended September 30, 2023 amounted to $1,081.
| NOTE 5: | REVENUE RECOGNITION |
|---|
Under ASC No. 606, “Revenue from Contracts with Customers” (“ASC 606”), an entity recognizes revenue when or as it satisfies a performance obligation by transferring intellectual property (“IP”) licenses or services to the customer, either at a point in time or over time. The Company recognizes most of its revenues at a point in time upon delivery when the customer accepts control of the IP. The Company recognizes revenue over time on significant license customization contracts that are in the scope of ASC 606 by using cost inputs to measure progress toward completion of its performance obligations.
Revenues that are derived from the sale of a licensee’s products that incorporate the Company’s IP are classified as royalty revenues. Royalty revenues are recognized during the quarter in which the sale of the product incorporating the Company’s IP occurs. Royalties are calculated either as a percentage of the revenues received by the Company’s licensees on sales of products incorporating the Company’s IP or on a per unit basis, as specified in the agreements with the licensees. When the Company does not receive actual sales data from the customer prior to the finalization of its financial statements, royalty revenues are recognized based on the Company’s estimation of the customer’s sales during the quarter.
The following table includes estimated revenue expected to be recognized in future periods related to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period. The estimated revenues do not include amounts of royalties or unexercised contract renewals:
| Remainder of 2024 | 2025 | 2026 and thereafter | |
|---|---|---|---|
| Licensing and related revenues | $3,421 | $11,098 | $2,725 |
Disaggregation of revenue:
The following table provides information about disaggregated revenue by primary geographical, use cases for the Company's technology portfolio, and timing of revenue recognition:
| Nine months ended September 30, 2024 (unaudited) | Three months ended September 30, 2024 (unaudited) | |||||
|---|---|---|---|---|---|---|
| Licensing and related revenues | Royalties | Total | Licensing and related revenues | Royalties | Total | |
| Geography | ||||||
| United States | $7,985 | $4,037 | $12,022 | $7,174 | $945 | $8,119 |
| Europe and Middle East | 8,318 | 3,326 | 11,644 | 1,473 | 1,217 | 2,690 |
| Asia Pacific | 27,950 | 26,087 | 54,037 | 6,927 | 9,471 | 16,398 |
| Other | 13 | — | 13 | — | — | — |
| Total | $44,266 | $33,450 | $77,716 | $15,574 | $11,633 | $27,207 |
| Use cases for the Company’s technology portfolio | ||||||
| Connect (baseband for handset and other devices, Bluetooth, Wi-Fi and NB-IoT) | $39,283 | $25,533 | $64,816 | $12,960 | $8,801 | $21,761 |
| Sense & Infer (sensor fusion, audio, sound, imaging, vision and AI) | 4,983 | 7,917 | 12,900 | 2,614 | 2,832 | 5,446 |
| Total | $44,266 | $33,450 | $77,716 | $15,574 | $11,633 | $27,207 |
| Timing of revenue recognition | ||||||
| Products transferred at a point in time | $38,154 | $33,450 | $71,604 | $13,431 | $11,633 | $25,064 |
| Products and services transferred over time | 6,112 | — | 6,112 | 2,143 | — | 2,143 |
| Total | $44,266 | $33,450 | $77,716 | $15,574 | $11,633 | $27,207 |
| Nine months ended September 30, 2023 (unaudited) | Three months ended September 30, 2023 (unaudited) | |||||
|---|---|---|---|---|---|---|
| Licensing and related revenues | Royalties | Total | Licensing and related revenues | Royalties | Total | |
| Geography | ||||||
| United States | $1,399 | $4,269 | $5,668 | $360 | $1,208 | $1,568 |
| Europe and Middle East | 8,378 | 2,140 | 10,518 | 4,796 | 828 | 5,624 |
| Asia Pacific | 35,442 | 21,109 | 56,551 | 8,765 | 8,097 | 16,862 |
| Other | 520 | — | 520 | 19 | — | 19 |
| Total | $45,739 | $27,518 | $73,257 | $13,940 | $10,133 | $24,073 |
| Use cases for the Company’s technology portfolio | ||||||
| Connect (baseband for handset and other devices, Bluetooth, Wi-Fi and NB-IoT) | $40,787 | $20,093 | $60,880 | $13,120 | $7,648 | $20,768 |
| Sense & Infer (sensor fusion, audio, sound, imaging, vision and AI) | 4,952 | 7,425 | 12,377 | 820 | 2,485 | 3,305 |
| Total | $45,739 | $27,518 | $73,257 | $13,940 | $10,133 | $24,073 |
| Timing of revenue recognition | ||||||
| Products transferred at a point in time | $36,504 | $27,518 | $64,022 | $11,479 | $10,133 | $21,612 |
| Products and services transferred over time | 9,235 | — | 9,235 | 2,461 | — | 2,461 |
| Total | $45,739 | $27,518 | $73,257 | $13,940 | $10,133 | $24,073 |
Contract balances:
The following table provides information about trade receivables, unbilled receivables and contract liabilities from contracts with customers:
| September 30, 2024 | December 31, 2023 | |
|---|---|---|
| Currents assets (classified under “Trade receivables”): | ||
| Trade receivables | $15,250 | $8,433 |
| Unbilled receivables (associated with licensing and related revenue) | 12,522 | 9,735 |
| Unbilled receivables (associated with royalties) | 10,858 | 12,139 |
| Total current assets | 38,630 | 30,307 |
| Long-term assets (classified under “Other long-term assets”): | ||
| Unbilled receivables (associated with licensing and related revenue) | 2,733 | — |
| Deferred revenues (short-term contract liabilities) | 3,418 | 3,018 |
The Company receives payments from customers based upon contractual payment schedules; trade receivables are recorded when the right to consideration becomes unconditional, and an invoice is issued to the customer. Unbilled receivables associated with licensing and other include amounts related to the Company’s contractual right to consideration for completed performance objectives not yet invoiced. Unbilled receivables associated with royalties are recorded as the Company recognizes revenues from royalties earned during the quarter, but not yet invoiced, either by actual sales data received from customers, or, when applicable, by the Company’s estimation. Contract liabilities (deferred revenue) include payments received in advance of performance under the contract and are realized with the associated revenue recognized under the contract.
During the three and nine months ended September 30, 2024, the Company recognized $235 and $2,158, respectively, that was included in deferred revenues (short-term contract liability) balance at January 1, 2024.
| NOTE 6: | LEASES |
|---|
The Company leases substantially all of its office space and vehicles under operating leases. The Company's leases have original lease periods expiring between 2025 and 2034. Many leases include one or more options to renew. The Company does not assume renewals in its determination of the lease term unless the renewals are deemed to be reasonably certain. Lease payments included in the measurement of the lease liability comprise the following: the fixed non-cancelable lease payments, payments for optional renewal periods where it is reasonably certain the renewal period will be exercised, and payments for early termination options unless it is reasonably certain the lease will not be terminated early.
The following is a summary of weighted average remaining lease terms and discount rates for all of the Company’s operating leases:
| September 30, 2024 (Unaudited) | |
|---|---|
| Weighted average remaining lease term (years) | 3.81 |
| Weighted average discount rates | 3.89% |
Total operating lease cost and cash payments for operating leases were as follows:
| Nine months ended September 30, | Three months ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| (unaudited) | (unaudited) | (unaudited) | (unaudited) | |
| Operating lease cost | $2,053 | $2,279 | $696 | $777 |
| Cash payments for operating leases | 2,022 | 2,255 | 713 | 771 |
Maturities of lease liabilities are as follows:
| The remainder of 2024 | $821 |
| 2025 | 2,118 |
| 2026 | 946 |
| 2027 | 651 |
| 2028 | 343 |
| 2029 and thereafter | 647 |
| Total undiscounted cash flows | 5,526 |
| Less imputed interest | 328 |
| Present value of lease liabilities | $5,198 |
| NOTE 7: | MARKETABLE SECURITIES |
|---|
The following is a summary of available-for-sale marketable securities:
| September 30, 2024 (Unaudited) | ||||
|---|---|---|---|---|
| Amortized cost | Gross unrealized gains | Gross unrealized losses | Fair value | |
| Available-for-sale - matures within one year: | ||||
| Corporate bonds | $64,156 | $74 | $(318) | $63,912 |
| Available-for-sale - matures after one year through three years: | ||||
| Corporate bonds | 79,824 | 651 | (1,509) | 78,966 |
| Total | ||||
| $143,980 | $725 | $(1,827) | $142,878 | |
| Amortized cost | Gross unrealized gains | Gross unrealized losses | Fair value | |
|---|---|---|---|---|
| Available-for-sale - matures within one year: | ||||
| Corporate bonds | $27,690 | $4 | $(243) | $27,451 |
| Available-for-sale - matures after one year through three years: | ||||
| Corporate bonds | 108,700 | 278 | (3,734) | 105,244 |
| Total | $136,390 | $282 | $(3,977) | $132,695 |
The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of September 30, 2024, and December 31, 2023, and the length of time that those investments have been in a continuous loss position:
| Less than 12 months | 12 months or greater | |||
|---|---|---|---|---|
| Fair value | Gross unrealized loss | Fair value | Gross unrealized loss | |
| As of September 30, 2024 (unaudited) | $4,300 | $(30) | $63,822 | $(1,797) |
| As of December 31, 2023 | $18,193 | $(49) | $86,643 | $(3,928) |
As of September 30, 2024, the allowance for credit losses was not material.
The following table presents gross realized gains and losses from sale of available-for-sale marketable securities:
| Nine months ended September 30, | Three months ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| (unaudited) | (unaudited) | (unaudited) | (unaudited) | |
| Gross realized gains from sale of available-for-sale marketable securities | $19 | $92 | $4 | $— |
| Gross realized losses from sale of available-for-sale marketable securities | $(5) | $(24) | $— | $(8) |
| NOTE 8: | FAIR VALUE MEASUREMENT |
|---|
FASB ASC No. 820, “Fair Value Measurements and Disclosures” defines fair value, establishes a framework for measuring fair value. Fair value is an exit price, representing the amount that would be received for selling an asset or paid for the transfer of a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:
| Level I | Unadjusted quoted prices in active markets that are accessible on the measurement date for identical, unrestricted assets or liabilities; |
|---|---|
| Level II | Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; and |
| Level III | Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity). |
The Company measures its marketable securities, investments in marketable equity securities and foreign currency derivative contracts at fair value. The carrying amount of cash, cash equivalents, short-term bank deposits, trade receivables, other accounts receivable, trade payables and other accounts payables approximate fair value due to the short-term maturity of these instruments. Investments in marketable equity securities are classified within Level I as the securities are traded in an active market. Marketable securities and foreign currency derivative contracts are classified within Level II as the valuation inputs are based on quoted prices and market observable data of similar instruments.
The table below sets forth the Company’s assets and liabilities measured at fair value by level within the fair value hierarchy. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.
| Description | September 30, 2024 (unaudited) | Level I (unaudited) | Level II (unaudited) | Level III (unaudited) |
|---|---|---|---|---|
| Assets: | ||||
| Marketable securities: | ||||
| Corporate bonds | $142,878 | $— | $142,878 | $— |
| Foreign exchange contracts | 22 | — | 22 | — |
| Investments in marketable equity securities | 309 | 309 | — | — |
| Description | December 31, 2023 | Level I | Level II | Level III |
|---|---|---|---|---|
| Assets: | ||||
| Marketable securities: | ||||
| Corporate bonds | $132,695 | $— | $132,695 | $— |
| Foreign exchange contracts | 988 | — | 988 | — |
| Investments in marketable equity securities | 406 | 406 | — | — |
| NOTE 9: | GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER DATA |
|---|
| a. | Summary information about geographic areas: |
The Company manages its business on the basis ofone reportable segment: the licensing of intellectual property to semiconductor companies and electronic equipment manufacturers (see Note 1 for a brief description of the Company’s business). The following is a summary of revenues within geographic areas:
| Nine months ended September 30, · Three months ended September 30, | |||||||
|---|---|---|---|---|---|---|---|
| 2024 (unaudited) · 2023 (unaudited) · 2024 (unaudited) · 2023 (unaudited) | |||||||
| Revenues based on customer location: | |||||||
| United States | $12,022 | $5,668 | $8,119 | $1,568 | |||
| Europe and Middle East | 11,644 | 10,518 | 2,690 | 5,624 | |||
| Asia Pacific (1, 2) | 54,037 | 56,551 | 16,398 | 16,862 | |||
| Other | 13 | 520 | — | 19 | |||
| $77,716 | $73,257 | $27,207 | $24,073 | ||||
| (1) China | $39,748 | $42,978 | $10,723 | $12,538 | |||
| (2) South Korea | * | ) | * | ) | $3,033 | * | ) |
*) Less than 10%
| b. | Major customer data as a percentage of total revenues: |
The following table sets forth the customers that represented 10% or more of the Company’s total revenues in each of the periods set forth below.
| Nine months ended September 30, · Three months ended September 30, | |||||||
|---|---|---|---|---|---|---|---|
| 2024 (unaudited) · 2023 (unaudited) · 2024 (unaudited) · 2023 (unaudited) | |||||||
| Customer A | 13% | 10% | 13% | 14% | |||
| Customer B | * | ) | — | 17% | — | ||
| Customer C | * | ) | * | ) | * | ) | 14% |
| Customer D | * | ) | * | ) | — | 12% | |
*) Less than 10%
| NOTE 10: | NET LOSS PER SHARE OF COMMON STOCK |
|---|
Basic net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding during each period. Diluted net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding during each period, plus dilutive potential shares of common stock considered outstanding during the period, in accordance with FASB ASC No. 260, “Earnings Per Share.”
| Nine months ended September 30, | Three months ended September 30, | |||
|---|---|---|---|---|
| 2024 (unaudited) | 2023 (unaudited) | 2024 (unaudited) | 2023 (unaudited) | |
| Numerator: | ||||
| Net loss from continuing operations | $(7,050) | $(10,339) | $(1,311) | $(2,750) |
| Net loss from discontinued operations | — | (5,308) | — | (2,207) |
| Net loss | $(7,050) | $(15,647 | $(1,311) | $(4,957) |
| Denominator (in thousands): | ||||
| Basic and diluted weighted-average common stock outstanding | 23,605 | 23,473 | 23,678 | 23,605 |
| Basic and diluted net loss per share from continuing operations | $(0.30) | $(0.44) | $(0.06) | $(0.12) |
| Basic and diluted net loss per share from discontinued operations | $— | (0.23) | $— | $(0.09) |
| Basic and diluted net loss per share | $(0.30) | $(0.67) | $(0.06) | $(0.21) |
The total number of shares related to outstanding equity-based awards was 1,684,428 for both the three and nine months ended September 30, 2024, and in each case was excluded from the calculation of diluted net loss per share. The total number of shares related to outstanding equity-based awards was 1,402,978 for both the three and nine months ended September 30, 2023, and in each case was excluded from the calculation of diluted net loss per share.
| NOTE 11: | COMMON STOCK AND STOCK-BASED COMPENSATION PLANS |
|---|
The Company has historically granted a mix of stock options, stock appreciation rights (“SARs”) capped with a ceiling and restricted stock units (“RSUs”) to employees and non‑employee directors of the Company and its subsidiaries under the Company’s equity plans and provides the right to purchase common stock pursuant to the Company’s 2002 employee stock purchase plan to employees of the Company and its subsidiaries. As of September 30, 2024, and December 31, 2023, there wereno outstanding or exercisable SARs left.
The options granted under the Company’s stock incentive plans have been granted at the fair market value of the Company’s common stock on the grant date. Options granted to employees under stock incentive plans generally vest at a rate of 25% of the shares underlying the option after one year and the remaining shares vest in equal portions over the following 36 months, such that all shares are vested after four years. A summary of the Company’s stock option activities and related information for the nine months ended September 30, 2024, are as follows:
| Number of options | Weighted average exercise price | Weighted average remaining contractual term | Aggregate intrinsic value | |
|---|---|---|---|---|
| Outstanding as of December 31, 2023 | 99,425 | $20.74 | 2.5 | $316 |
| Granted | 10,600 | 19.61 | ||
| Exercised | (26,000) | 14.77 | ||
| Forfeited or expired | — | — | ||
| Outstanding as of September 30, 2024 (unaudited) | 84,025 | $22.45 | 3.0 | $225 |
| Exercisable as of September 30, 2024 (unaudited) | 59,260 | $23.15 | 1.7 | $141 |
As of September 30, 2024, there was $257 of unrecognized compensation expense related to unvested stock options. This amount is expected to be recognized over a weighted-average period of 2.1 years.
An RSU award is an agreement to issue shares of the Company’s common stock at the time the award or a portion thereof vests. RSUs granted to employees generally vest inthree equal annual installments starting on thefirst anniversary of the grant date. RSUs granted to non-employee directors would generally vest intwo equal annual installments starting on thefirst anniversary of the grant date.
On February 12, 2024, the Compensation Committee of the Board (the “Committee”) granted 33,318,20,043,16,399 and 13,535 RSUs, effective as of February 16, 2024, to each of the Company’s Chief Executive Officer (“CEO”), Chief Financial Officer (“CFO”), Chief Operating Officer (“COO”) and Chief Commercial Officer (“CCO”), respectively, pursuant to the Company’s 2011 Stock Incentive Plan (the “2011 Plan”). The RSU grants vest 33.4% on February 16, 2025,33.3% on February 16, 2026 and 33.3% on February 16, 2027.
Also, on February 12, 2024, the Committee granted 49,978,13,362,10,932 and 9,023 performance-based restricted stock units (“PSUs”), effective as of February 16, 2024, to each of the Company’s CEO, CFO, COO and CCO, respectively, pursuant to the 2011 Plan. The performance goals for the PSUs with specified weighting are as follows:
| Weighting | Goals |
| 50% | Vesting of the full 50% of the PSUs occurs if the Company achieves the 2024 license and related revenue target approved by the Board (the “2024 License Revenue Target”). The vesting threshold is achievement of 90% of the 2024 License Revenue Target. If the Company’s achievement of the 2024 License Revenue Target is above 90% but less than 99% of the 2024 License Revenue Target, 91% to 99% of the eligible PSUs would be subject to vesting. If the Company’s actual result exceeds 100% of the 2024 License Revenue Target, every 1% increase of the 2024 License Revenue Target, up to 120%, would result in an increase of 2% of the eligible PSUs for the Company’s CFO, COO and CCO and an increase of 3% of the eligible PSUs for the Company’s CEO. |
| 25% | Vesting of the full 25% of the PSUs occurs if the Company achieves positive total shareholder return whereby the return on the Company’s stock for 2024 is greater than the S&P Semiconductors Select Industry index (the “S&P index”). The vesting threshold is if the return on the Company’s stock for 2024 is at least 90% of the S&P index. If the return on the Company’s stock, in comparison to the S&P index, is above 90% but less than 99% of the S&P index, 91% to 99% of the eligible PSUs would be subject to vesting. If the return on the Company’s stock exceeds 100% of the S&P index, every 1% increase in comparison to the S&P index, up to 120%, would result in an increase of 2% of the eligible PSUs for the Company’s CFO, COO and CCO and an increase of 3% of the eligible PSUs for the Company’s CEO. |
| 25% | Vesting of the full 25% of the PSUs occurs if the Company achieves positive total shareholder return whereby the return on the Company’s stock for 2024 is greater than the Russell 2000 index (the “Russell index”). The vesting threshold is if the return on the Company’s stock for 2024 is at least 90% of the Russell index. If the return on the Company’s stock, in comparison to the Russell index, is above 90% but less than 99% of the Russell index, 91% to 99% of the eligible PSUs would be subject to vesting. If the return on the Company’s stock exceeds 100% of the Russell index, every 1% increase in comparison to the Russell index, up to 120%, would result in an increase of 2% of the eligible PSUs for the Company’s CFO, COO and CCO and an increase of 3% of the eligible PSUs for the Company’s CEO. |
Accordingly, assuming maximum achievement of the performance goals set forth above, PSUs representing an additional 60%, meaning an additional 29,986, would be eligible for vesting of the Company’s CEO, and an additional 40%, meaning an additional 5,344,4,372 and 3,609, would be eligible for vesting for each of the Company’s CFO, COO and CCO, respectively.
Subject to achievement of the thresholds the above performance goals for 2024, the PSUs vest 33.4% on February 16, 2025,33.3% on February 16, 2026 and 33.3% on February 16, 2027.
A summary of the Company’s RSU and PSU activities and related information for the nine months ended September 30, 2024, are as follows:
| Number of RSUs and PSUs | Weighted Average Grant- Date Fair Value | |
|---|---|---|
| Unvested as of December 31, 2023 | 1,281,751 | $24.97 |
| Granted | 859,496 | 19.64 |
| Vested | (373,472) | 31.48 |
| Forfeited or expired | (167,372) | 21.35 |
| Unvested as of September 30, 2024 (unaudited) | 1,600,403 | $20.95 |
As of September 30, 2024, there was $23,612 of unrecognized compensation expense related to unvested RSUs and PSUs. This amount is expected to be recognized over a weighted-average period of 1.6 years.
The following table shows the total equity-based compensation expense included in the interim condensed consolidated statements of loss:
| Nine months ended September 30, | Three months ended September 30, | |||
|---|---|---|---|---|
| 2024 (unaudited) | 2023 (unaudited) | 2024 (unaudited) | 2023 (unaudited) | |
| Cost of revenue | $570 | $636 | $176 | $216 |
| Research and development, net | 6,866 | 6,703 | 2,421 | 2,257 |
| Sales and marketing | 1,307 | 1,305 | 491 | 478 |
| General and administrative | 2,936 | 2,787 | 1,120 | 1,018 |
| Total equity-based compensation expense from continuing operations | 11,679 | 11,431 | 4,208 | 3,969 |
| Equity-based compensation expense included in discontinued operations | — | 875 | — | 273 |
| Total equity-based compensation expense | $11,679 | $12,306 | $4,208 | $4,242 |
The fair value for rights to purchase shares of common stock under the Company’s employee stock purchase plan was estimated on the date of grant using the following assumptions:
| Nine months ended September 30 | Three months ended September 30 | |||
|---|---|---|---|---|
| 2024 (unaudited) | 2023 (unaudited) | 2024 (unaudited) | 2023 (unaudited) | |
| Expected dividend yield | 0% | 0% | 0% | 0% |
| Expected volatility | 46%-50% | 45%-47% | 50% | 47% |
| Risk-free interest rate | 4.9%-5.3% | 4.8%-5.5% | 4.9% | 5.5% |
| Contractual term of up to (months) | 6 | 6 | 6 | 6 |
| NOTE 12: | DERIVATIVES AND HEDGING ACTIVITIES |
|---|
The Company follows the requirements of FASB ASC No. 815,” Derivatives and Hedging” which requires companies to recognize all of their derivative instruments as either assets or liabilities in the statement of financial position at fair value. The accounting for changes in fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging transaction and further, on the type of hedging transaction. For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. Due to the Company’s global operations, it is exposed to foreign currency exchange rate fluctuations in the normal course of its business. The Company’s treasury policy allows it to offset the risks associated with the effects of certain foreign currency exposures through the purchase of foreign exchange forward or option contracts (“Hedging Contracts”). The policy, however, prohibits the Company from speculating on such Hedging Contracts for profit. To protect against the increase in value of forecasted foreign currency cash flow resulting from salaries paid in currencies other than the U.S. dollar during the year, the Company instituted a foreign currency cash flow hedging program. The Company hedges portions of the anticipated payroll of its non-U.S. employees denominated in the currencies other than the U.S. dollar for a period of one to twelve months with Hedging Contracts. Accordingly, when the dollar strengthens against the foreign currencies, the decline in present value of future foreign currency expenses is offset by losses in the fair value of the Hedging Contracts. Conversely, when the dollar weakens, the increase in the present value of future foreign currency expenses is offset by gains in the fair value of the Hedging Contracts. These Hedging Contracts are designated as cash flow hedges.
For derivative instruments that are designated and qualify as a cash flow hedge (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk), the gain or loss on the derivative instrument is reported as a component of other comprehensive income (loss) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. As of September 30, 2024, and December 31, 2023, the notional principal amount of the Hedging Contracts to sell U.S. dollars held by the Company was $900 and $16,500, respectively.
The fair value of the Company’s outstanding derivative instruments is as follows:
| September 30, 2024 (unaudited) | December 31, 2023 | |
|---|---|---|
| Derivative assets: | ||
| Derivatives designated as cash flow hedging instruments: | ||
| Foreign exchange forward contracts | $22 | $988 |
| Total | $22 | $988 |
The increase (decrease) in unrealized gains (losses) recognized in “accumulated other comprehensive gain (loss)” on derivatives, before tax effect, is as follows:
| Nine months ended September 30, | Three months ended September 30, | |||
|---|---|---|---|---|
| 2024 (unaudited) | 2023 (unaudited) | 2024 (unaudited) | 2023 (unaudited) | |
| Derivatives designated as cash flow hedging instruments: | ||||
| Foreign exchange option contracts | $41 | $(328) | $25 | $(130) |
| Foreign exchange forward contracts | (240) | (678) | 115 | (246) |
| $(199) | $(1,006) | $140 | $(376) | |
The net (gains) losses reclassified from “accumulated other comprehensive gain (loss)” into income are as follows:
| Nine months ended September 30, | Three months ended September 30, | |||
|---|---|---|---|---|
| 2024 (unaudited) | 2023 (unaudited) | 2024 (unaudited) | 2023 (unaudited) | |
| Derivatives designated as cash flow hedging instruments: | ||||
| Foreign exchange option contracts | $(41) | $253 | $(16) | $141 |
| Foreign exchange forward contracts | (726) | 620 | (144) | 158 |
| $(767) | $873 | $(160) | $299 | |
The Company recorded in cost of revenues and operating expenses a net gain of $160 and $767 during the three and nine months ended September 30, 2024, respectively, and a net loss of $299 and $873 during the comparable periods of 2023, related to its Hedging Contracts.
| NOTE 13: | ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) |
|---|
The following tables summarize the changes in accumulated balances of other comprehensive income (loss), net of taxes:
| Nine months ended September 30, 2024 (unaudited) | Three months ended September 30, 2024 (unaudited) | |||||
|---|---|---|---|---|---|---|
| Unrealized gains (losses) on available- for- sale marketable securities | Unrealized gains (losses) on cash flow hedges | Total | Unrealized gains (losses) on available- for- sale marketable securities | Unrealized gains (losses) on cash flow hedges | Total | |
| Beginning balance | $(3,317) | $988 | $(2,329) | $(2,936) | $42 | $(2,894) |
| Other comprehensive income (loss) before reclassifications | 2,353 | (200) | 2,153 | 1,962 | 140 | 2,102 |
| Amounts reclassified from accumulated other comprehensive income (loss) | (14) | (766) | (780) | (4) | (160) | (164) |
| Net current period other comprehensive income (loss) | 2,339 | (966) | 1,373 | 1,958 | (20) | 1,938 |
| Ending balance | $(978) | $22 | $(956) | $(978) | $22 | $(956) |
| Nine months ended September 30, 2023 (unaudited) | Three months ended September 30, 2023 (unaudited) | |||||
|---|---|---|---|---|---|---|
| Unrealized gains (losses) on available- for- sale marketable securities | Unrealized gains (losses) on cash flow hedges | Total | Unrealized gains (losses) on available- for- sale marketable securities | Unrealized gains (losses) on cash flow hedges | Total | |
| Beginning balance | $(6,142) | $(107) | $(6,249) | $(5,421) | $(162) | $(5,583) |
| Other comprehensive income (loss) before reclassifications | 981 | (1,006) | (25) | 183 | (375) | (192) |
| Amounts reclassified from accumulated other comprehensive income (loss) | (69) | 874 | 805 | 8 | 298 | 306 |
| Net current period other comprehensive income (loss) | 912 | (132) | 780 | 191 | (77) | 114 |
| Ending balance | $(5,230) | $(239) | $(5,469) | $(5,230) | $(239) | $(5,469) |
The following table provides details about reclassifications out of accumulated other comprehensive income (loss):
| Details about Accumulated Other Comprehensive Income (Loss) Components · Amount Reclassified from Accumulated Other Comprehensive Income (Loss) · Affected Line Item in the Statements of Income (Loss) | |||||
|---|---|---|---|---|---|
| Nine months ended September 30, · Three months ended September 30, | |||||
| 2024 (unaudited) · 2023 (unaudited) · 2024 (unaudited) · 2023 (unaudited) | |||||
| Unrealized gains (losses) on cash flow hedges | $17 | $(17) | $4 | $(6) | Cost of revenues |
| 653 | (755) | 135 | (260) | Research and development | |
| 19 | (19) | 4 | (6) | Sales and marketing | |
| 78 | (82) | 17 | (27) | General and administrative | |
| 767 | (873) | 160 | (299) | Total, before income taxes | |
| 1 | 1 | — | (1) | Income tax expense (benefit) | |
| 766 | (874) | 160 | (298) | Total, net of income taxes | |
| Unrealized gains (losses) on available-for-sale marketable securities | 14 | 68 | 4 | (8) | Financial income (loss), net |
| — | (1) | — | — | Income tax benefit | |
| 14 | 69 | 4 | (8) | Total, net of income taxes | |
| $780 | $(805) | $164 | $(306) | Total, net of income taxes | |
| NOTE 14: | SHARE REPURCHASE PROGRAM |
|---|
During the three months ended September 30, 2024, the Company repurchased 186,301 shares of common stock at an average purchase price of $22.44 per share for an aggregate purchase price of $4,180. During the nine months ended September 30, 2024, the Company repurchased 343,604 shares of common stock at an average purchase price of $21.70 per share for an aggregate purchase price of $7,456. During the three and nine months ended September 30, 2023, the Company repurchased 135,078 shares of common stock at an average purchase price of $22.23 per share for an aggregate purchase price of $3,003. As of September 30, 2024,356,396 shares of common stock remained available for repurchase pursuant to the Company’s share repurchase program.
The repurchases of common stock are accounted for as treasury stock, and result in a reduction of stockholders’ equity. When treasury shares are reissued, the Company accounts for the reissuance in accordance with FASB ASC No. 505-30, “Treasury Stock” and charges the excess of the repurchase cost over issuance price using the weighted average method to retained earnings. The purchase cost is calculated based on the specific identified method. In the case where the repurchase cost over issuance price using the weighted average method is lower than the issuance price, the Company credits the difference to additional paid-in capital.
| NOTE 15: | SUBSEQUENT EVENTS |
|---|
On November 7, 2024, the Board authorized and approved an expansion of the share repurchase program with an additional 700,000 shares of common stock available for repurchase, bringing the aggregate to approximately 1,056,000 shares available for repurchase as of that date.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.